Reply: ACE Inhibitors and Angiotensin II Receptor Blockers May Have Different Impact on Prognosis of COVID-19

J Am Coll Cardiol. 2020 Oct 27;76(17):2042. doi: 10.1016/j.jacc.2020.08.064.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Angiotensin Receptor Antagonists*
  • Angiotensin-Converting Enzyme Inhibitors*
  • Betacoronavirus
  • COVID-19
  • Coronavirus Infections*
  • Humans
  • Pandemics*
  • Pneumonia, Viral*
  • Prognosis
  • SARS-CoV-2

Substances

  • Angiotensin Receptor Antagonists
  • Angiotensin-Converting Enzyme Inhibitors